News & Events about Alaunos Therapeutics Inc.
Announcing addition of two new TCRs to the library, estimated to double the addressable market; plans to further expand TCR library using hunTR TCR discovery platformIncreasing patient enrollment to advance TCR-T Library Program towards Phase 2 using high value TCRs targeting common hotspot ...
Globe Newswire
2 months ago
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Alaunos or the Company) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced the pricing of its underwritten public offering of approximately24,228,719 shares of its common stock for gross ...
Globe Newswire
2 months ago
HOUSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Alaunos or the Company) (Nasdaq: TCRT), today announced that it will report financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022, before the open of U.S. markets. Following the ...
Globe Newswire
2 months ago
Data supports high-throughput screening process to identify neoantigen-reactive TCRsExclusive ownership of discovered KRAS mutation-reactive TCRshunTR enables expansion of the Companys hotspot mutation targeted TCR library HOUSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (...
Thinking about buying stock in Frontier Communications, Edgio, Alaunos Therapeutics, Heartbeam, or Blue Apron? Thinking about buying stock in Frontier Communications, Edgio, Alaunos Therapeutics, Heartbeam, or Blue Apron? PR Newswire NEW YORK, Sept. 28, 2022 NEW YORK, Sept. 28, 2022 /PRNewswire...